Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Personalized Diabetes Medicine Program, |
RCV001174497 | SCV001337636 | likely benign | Monogenic diabetes | 2018-06-29 | criteria provided, single submitter | research | ACMG criteria: BP4 (5 predictors + REVEL score 0.148; (3 predictors for PP3), BS2 (1 homozygotes in gnomAD; 18 cases and 21 controls in type2diabetesgenetics.org), not using BS1 (1% in 1000G African population but 0.7% in gnomAD African population) = likely benign |
Labcorp Genetics |
RCV001579507 | SCV002389935 | benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV003117803 | SCV003799924 | likely benign | Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001579507 | SCV005225191 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001579507 | SCV001970907 | uncertain significance | not provided | no assertion criteria provided | clinical testing |